Artoss Enters DAPA Agreement for NanoBone Graft Products

By Julie A. Vetalice

Artoss entered into a Defense Acquisition Purchasing Agreement (DAPA) with Owens & Minor for U.S. Department of Defense (DoD) purchase of all NanoBone bone graft products.

Artoss is the exclusive North American distributor for NanoBone in orthopaedic procedures. Owens & Minor is a Prime Vendor of NanoBone, and thus provides products at a contracted price to Federal and military customers that are grouped into a region. This agreement allows surgeons in any U.S. DoD healthcare facility to purchase NanoBone from Artoss.

NanoBone Bone Graft products have been used in Europe and the U.S. for >10 years in nearly 400,000 clinical cases across all indications, and were introduced to the U.S. via Artoss in 2015.

Source: Artoss, Inc.

Product Labels: Bone Graft Materials/DBM

Tags: M&A